Apotex recalls its drug in the US
17 July 2015 | News | By BioSpectrum Bureau
Apotex recalls its drug in the US
It has been classified as a class-II recall
Apotex is recalling 91,962 bottles of Losartan potassium tablets in the US, due to "failed content uniformity specifications."
The drugs were manufactured by the company's Indian arm Apotex Research Pvt Ltd.
It has been classified as a class-II recall which FDA defined as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
